Role of home telemonitoring of lung function using the forced oscillation technique in predicting exacerbations and control among moderate-severe asthmatics during down-titration of treatment: a pragmatic, observational study

Woolcock Institute of Medical Research0 个研究点目标入组 40 人开始时间: 2017年12月22日最近更新: 2019年1月28日

适应症

试验速览

暂无简介。

•Inclusion Criteria:
•above 18 years of age,
•diagnosis of asthma, confirmed by written report from a physician, and
•receiving maintenance asthma treatment at at least Step 4 (on moderate to high dose of ICS (budesonide >500 mcg/day or fluticasone propionate >200 mcg/day or equivalent and LABA treatment) of Australian guidelines, and
•ACQ-5 score <1.5, consistent with adequate symptom control,
•All patients will be eligible if their physician is considering stepping down their treatment, from step 4 (the most commonly prescribed asthma treatment in Australia) to step 3, by reducing their regular maintenance inhaled corticosteroid (ICS) dose by 50%, as recommended by Australian guidelines (see http://www.asthmahandbook.org.au/management/adults/stepped-adjustment/stepping-down).

•any other confounding major disease or condition as deemed appropriate by investigator, determined by review of medical history and/or patient reported medical history, and
•impaired ability to understand instructions or perform FOT unsupervised.

发起方